B-Cell CLL-Lymphoma 10 Protein

• 

  Subject Areas on Research

  • A loss-of-function RNA interference screen for molecular targets in cancer. 
  • Bcl10 is not a target for frequent mutation in human carcinomas. 
  • Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs. 
  • Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB. 
  • T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.